Tegafur/Leucovorin calcium/Gimeracil/Oteracil Potassium

替加氟/亚叶酸钙/吉莫斯特/氧嗪酸钾

Report date: 2025/05/01 20:00:06

Base Information

Drug NameTegafur/Leucovorin calcium/Gimeracil/Oteracil Potassium
Drug Alias NameTegafur/Gimeracil/Oteracil potassium/Leucovorin calcium亚叶酸钙/替加氟/吉美嘧啶/氧嗪酸钾Calcium folinate/Gimeracil/Oteracil potassium/Tegafurtegafur + gimeracil + oteracil potassium + calcium folinateTAS-118
ClassificationSmall molecules
Mechanisms of ActionThymidylate synthase inhibitorsDNA synthesis inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaJapan
CombinationsYes TegafurLeucovorin calciumGimeracil
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTaiho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaiho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A